Biofrontera: Jumps on plans to resolve legal disputes with shareholders
** Germany-based skin treatment developer's U.S.-listed
shares BFRA.O soar 34.2% to $9.90 - stock among top pct.
gainers across U.S. exchanges
** Company says it has reached an agreement with shareholder
Deutsche Balaton and its majority shareholder, Wilhelm Zours, to
get a mediator to resolve legal disputes related to personnel
and strategic corporate matters urn:newsml:reuters.com:*:nGNX4v9dqD
** More than 21.9 mln shares change hands, nearly 40-times
their 25-day moving average
** Session gains cut YTD losses to ~3%
(Reporting by Manas Mishra in Bengaluru)
((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manasmishra24))
Recent news on Biofrontera AG
See all newsBrief: Biofrontera Says Co And Units Have Entered Into An Agreement With Biofrontera Inc About How To Settle Payment Obligations By Biofrontera Inc
Brief: Biofrontera AG Says Legal Dispute On Import In USA Will Result In Revised Outlook
Brief: Biofrontera AG Resolves Capital Increase From Authorized Capital
Brief: Biofrontera AG Says Plans Capital Reduction And Considers Subsequent Capital Increase From Authorized Capital
Brief: Biofrontera AG Says FY 2022 Total Revenue Amounted To EUR 25.7 Million